Eastman Chemical Company (EMN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
10 May, 2026Executive summary
Sequential sales volume/mix in specialty businesses improved by over 10% from the previous quarter, driven by demand recovery, reduced customer caution, and strong cost discipline, despite global disruptions and Middle East conflict.
Implemented approximately $500 million in price increases across all segments to offset significant raw material and distribution inflation, with high customer acceptance.
Progressed with the Kingsport methanolysis facility ramp-up, contributing ~$30 million in incremental earnings and supporting circular platform growth.
Maintained momentum toward financial priorities, including year-over-year earnings growth, $125–$150 million in cost savings, and cash flow targets.
Net earnings attributable to shareholders were $107 million ($0.93 per diluted share), with adjusted net earnings of $125 million ($1.09 per diluted share).
Financial highlights
Q1 2026 sales revenue was $2,177 million, down 5% year-over-year; adjusted EBIT was $200 million, down from $311 million in 1Q25.
Adjusted EBIT margin improved sequentially to 9.2% from 6.8% in 4Q25, but down from 13.6% in 1Q25.
Net cash used in operating activities was $137 million, an improvement from $167 million in 1Q25.
Capital expenditures were $103 million in Q1 2026, with full-year 2026 targeted at ~$400 million.
Recognized a $20–$22 million benefit from the refund of previously paid IEEPA tariffs.
Outlook and guidance
Full-year 2026 earnings expected to improve significantly versus 2025, with 2Q26 adjusted EPS projected at $1.70–$1.90.
Targeting $125–$150 million in cost savings for 2026, with capital expenditures of ~$400 million, $150 million below 2025.
Operating cash flow expected to approach 2025 levels, though inflationary pressures and market volatility remain.
Specialty price increases and innovation-driven growth, especially from Renew and Kingsport methanolysis, expected to drive results.
Headwinds include weak consumer discretionary demand, lower auto OEM production, and Middle East conflict risks.
Latest events from Eastman Chemical Company
- Disciplined execution, innovation, and sustainability drive growth as board urges votes for all management proposals.EMN
Proxy filing24 Mar 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and special meeting threshold.EMN
Proxy filing24 Mar 2026 - Resilient performance, price actions, and recycling investments drive growth amid volatility.EMN
JPMorgan Industrials Conference 202618 Mar 2026 - Circular economy and innovation platforms drive EBITDA above $2.5B by 2029.EMN
Status Update3 Feb 2026 - Q2 2024 saw higher sales, margin gains, and robust cash flow, led by Advanced Materials.EMN
Q2 20242 Feb 2026 - Cost cuts, cash flow, and circular growth drive outlook despite weak demand and competition.EMN
Q4 20252 Feb 2026 - Circular economy projects advance as demand stabilizes and innovation drives segment growth.EMN
Deutsche Bank Global Industrial, Materials & Building Products Conference1 Feb 2026 - Methanolysis progress, plant expansion, and innovation drive recovery amid mixed global demand.EMN
Morgan Stanley‘s 12th Annual Laguna Conference 202420 Jan 2026 - Q3 2024 sales up 9% to $2.46B, with margin gains and innovation driving future growth.EMN
Q3 202417 Jan 2026